(*) EU CE Mark Date: 2020. 12.
(*) USA Approval Date: 2021. 12.22.
>siRNA Twice/Year Inj.
Company
Generic Name: Inclisiran
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 5
Patent>UpDate: 2021. 12.21
PCSK9: Proprotein Convertase Subti>
RTM
RTM Web-Site
siRNA: Short Interfering RNA